相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Repurposing Antimalarials to Tackle the COVID-19 Pandemic
Sanjeev Krishna et al.
TRENDS IN PARASITOLOGY (2021)
The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV
Nima Hemmat et al.
ARCHIVES OF VIROLOGY (2021)
Oxford-AstraZeneca COVID-19 vaccine efficacy
Maria Deloria Knoll et al.
LANCET (2021)
Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV
Jiabao Xu et al.
VIRUSES-BASEL (2020)
Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks
Hossam M. Ashour et al.
PATHOGENS (2020)
Montelukast, an Anti-asthmatic Drug, Inhibits Zika Virus Infection by Disrupting Viral Integrity
Yongkang Chen et al.
FRONTIERS IN MICROBIOLOGY (2020)
Structural and Evolutionary Analysis Indicate That the SARS-CoV-2 Mpro Is a Challenging Target for Small-Molecule Inhibitor Design
Maria Bzowka et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Discovery of direct-acting antiviral agents with a graphene-based fluorescent nanosensor
Se-Jin Park et al.
SCIENCE ADVANCES (2020)
Quinolines-Based SARS-CoV-2 3CLpro and RdRp Inhibitors and Spike-RBD-ACE2 Inhibitor for Drug-Repurposing Against COVID-19: Anin silicoAnalysis
Rajaiah Alexpandi et al.
FRONTIERS IN MICROBIOLOGY (2020)
p38 MAPK inhibition: A promising therapeutic approach for COVID-19
Joseph M. Grimes et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2020)
Repositioning of 8565 Existing Drugs for COVID-19
Kaifu Gao et al.
JOURNAL OF PHYSICAL CHEMISTRY LETTERS (2020)
The SARS-CoV-2 main protease as drug target
Sven Ullrich et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
As a potential treatment of COVID-19: Montelukast
Cihan Fidan et al.
MEDICAL HYPOTHESES (2020)
Drug repurposing approach to fight COVID-19
Thakur Uttam Singh et al.
PHARMACOLOGICAL REPORTS (2020)
Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: Anin silicoinsight
Mohd Imran Khan et al.
PLOS ONE (2020)
Statin use is associated with lower disease severity in COVID-19 infection
Wilnard Y. T. Tan et al.
SCIENTIFIC REPORTS (2020)
A Review of the Progress and Challenges of Developing a Vaccine for COVID-19
Omna Sharma et al.
FRONTIERS IN IMMUNOLOGY (2020)
FDA Approval of Remdesivir - A Step in the Right Direction
Daniel Rubin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease
Mohamed Mahdi et al.
VIROLOGY JOURNAL (2020)
Conserved interactions required for inhibition of the main protease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Alina Shitrit et al.
SCIENTIFIC REPORTS (2020)
Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against Mpro and cathepsin L
Michael Dominic Sacco et al.
SCIENCE ADVANCES (2020)
Identification of saquinavir as a potent inhibitor of dimeric SARS-CoV2 main protease through MM/GBSA
Martiniano Bello et al.
JOURNAL OF MOLECULAR MODELING (2020)
Repurposing therapeutics for COVID-19: Rapid prediction of commercially available drugs through machine learning and docking
Sovesh Mohapatra et al.
PLOS ONE (2020)
In silico drug discovery of major metabolites from spices as SARS-CoV-2 main protease inhibitors
Mahmoud A. A. Ibrahim et al.
COMPUTERS IN BIOLOGY AND MEDICINE (2020)
Potential role of medicinal plants and their constituents in the mitigation of SARS-CoV-2: identifying related therapeutic targets using network pharmacology and molecular docking analyses
Eman Shawky et al.
RSC ADVANCES (2020)
Drug targets for corona virus: A systematic review
Manisha Prajapat et al.
INDIAN JOURNAL OF PHARMACOLOGY (2020)
Drug repurposing for COVID-19 using machine learning and mechanistic models of signal transduction circuits related to SARS-CoV-2 infection
Carlos Loucera et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Drug Repurposing for Ebola Virus Disease: Principles of Consideration and the Animal Rule
Jane P. F. Bai et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Salvianolic Acids: Potential Source of Natural Drugs for the Treatment of Fibrosis Disease and Cancer
Lunkun Ma et al.
FRONTIERS IN PHARMACOLOGY (2019)
Repurposing an HIV Drug for Zika Virus Therapy
Xuping Xie et al.
MOLECULAR THERAPY (2019)
Proteases and protease inhibitors in infectious diseases
Ayodeji A. Agbowuro et al.
MEDICINAL RESEARCH REVIEWS (2018)
Drug repurposing from the perspective of pharmaceutical companies
Y. Cha et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Drug repurposing in cancer
Linda Sleire et al.
PHARMACOLOGICAL RESEARCH (2017)
Database resources of the National Center for Biotechnology Information
Richa Agarwala et al.
NUCLEIC ACIDS RESEARCH (2016)
Investigational p38 inhibitors for the treatment of chronic obstructive pulmonary disease
Peter Norman
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2015)
GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit
Sander Pronk et al.
BIOINFORMATICS (2013)
Characterizing Systemic Exposure of Inhaled Drugs: Application to the Long-Acting β2-Agonist PF-00610355
Paul Matthias Diderichsen et al.
CLINICAL PHARMACOKINETICS (2013)
Salvianolic acids: small compounds with multiple mechanisms for cardiovascular protection
Jennifer Hui-Chun Ho et al.
JOURNAL OF BIOMEDICAL SCIENCE (2011)
GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation
Berk Hess et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2008)
Molecular dynamic simulations analysis of ritronavir and lopinavir as SARS-CoV 3CLpro inhibitors
Veena Nukoolkarn et al.
JOURNAL OF THEORETICAL BIOLOGY (2008)
Molecular biology of severe acute respiratory syndrome coronavirus
J Ziebuhr
CURRENT OPINION IN MICROBIOLOGY (2004)
The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor
HT Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Coronavirus main proteinase (3CLpro) structure:: Basis for design of anti-SARS drugs
K Anand et al.
SCIENCE (2003)
Structures of Ser205 mutant plasmepsin II from Plasmodium falciparum at 1.8 Å in complex with the inhibitors rs367 and rs370
OA Asojo et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2002)
Montelukast - A review of its therapeutic potential in persistent asthma
B Jarvis et al.
DRUGS (2000)
分享论文
